Greenlight Re (GLRE)
Writes global P&C reinsurance while investing through the Solasglas portfolio.
$15.25
At close−0.01 (−0.07%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 169 | 155 | 168 | 171 | 168 | 136 | 180 | 178 | 160 | 178 | 161 | 165 |
| Cost of revenue | 144 | 118 | 151 | 152 | 139 | 161 | 170 | 147 | 136 | −41 | 91 | 156 |
| Gross profit | 25 | 36 | 17 | 18 | 29 | −25 | 10 | 31 | 25 | 219 | 70 | 9 |
| 11 | 19 | −10 | 10 | −7 | 3 | −21 | 31 | 29 | 168 | 34 | 39 | |
| 3 | 10 | 4 | 5 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| General & administrative | 3 | 10 | 4 | 5 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 8 | 9 | −15 | 5 | −11 | 3 | −21 | 31 | 29 | 168 | 34 | 39 |
| Operating income | 14 | 18 | 28 | 8 | 36 | −28 | 31 | 1 | −4 | 51 | 36 | −29 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 10 | 9 | 9 | 8 | 8 | 7 | 7 | 7 | 7 | 5 | 0 | 5 |
| Interest expense | 2 | 4 | 2 | 3 | 2 | 1 | 2 | 1 | 2 | 0 | 0 | 0 |
| Other non-operating income | −2 | −4 | −2 | −3 | −2 | −1 | −2 | −1 | −2 | 0 | 0 | 0 |
| Income before tax | 14 | 18 | 28 | 8 | 36 | −28 | 31 | 1 | −4 | 51 | 36 | −29 |
| Income tax expense | 0 | 0 | 1 | 0 | 1 | −1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Net income from continuing operations | 13 | 18 | 27 | 8 | 35 | −27 | 30 | 0 | −4 | 49 | 36 | −30 |
| Net income | 13 | 18 | 27 | 8 | 35 | −27 | 30 | 0 | −4 | 49 | 36 | −30 |
| EPS, basic | $0.40 | $0.50 | $0.79 | $0.23 | $1.03 | −$0.81 | $0.87 | $0.01 | −$0.13 | $1.46 | $1.06 | −$0.89 |
| EPS, diluted | $0.39 | $0.50 | $0.78 | $0.23 | $1.01 | −$0.81 | $0.86 | $0.01 | −$0.13 | $1.43 | $1.05 | −$0.89 |
| Weighted average shares, basic | 34 | 35 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 33 |
| Weighted average shares, diluted | 35 | 35 | 35 | 35 | 35 | 34 | 34 | 34 | 34 | 35 | 34 | 33 |
| EBITDA | 15 | 22 | 30 | 12 | 38 | −27 | 33 | 2 | −2 | 51 | 36 | −29 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 15 | 22 | 30 | 12 | 38 | −27 | 33 | 2 | −2 | 51 | 36 | −29 |
